In tumor cells, approximately 10% of the glycolytic intermediate 3-phosphoglycerate is oxidized into the serine precursor 3-phosphohydroxypyruvate in a reaction catalyzed by phosphoglycerate dehydrogenase (PHGDH) using NAD+ as a cofactor. Here, PHGDH is linked to neoplasm.